Beijing Aosaikang Pharmaceutical Co (SZSE:002755) Total Liabilities : ¥651 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Beijing Aosaikang Pharmaceutical Co Total Liabilities?

Beijing Aosaikang Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥651 Mil.

Beijing Aosaikang Pharmaceutical Co's quarterly Total Liabilities declined from Sep. 2023 (¥598.78 Mil) to Dec. 2023 (¥513.20 Mil) but then increased from Dec. 2023 (¥513.20 Mil) to Mar. 2024 (¥650.80 Mil).

Beijing Aosaikang Pharmaceutical Co's annual Total Liabilities declined from Dec. 2021 (¥497.24 Mil) to Dec. 2022 (¥401.03 Mil) but then increased from Dec. 2022 (¥401.03 Mil) to Dec. 2023 (¥513.20 Mil).

Beijing Aosaikang Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Beijing Aosaikang Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Aosaikang Pharmaceutical Co Total Liabilities Chart

Beijing Aosaikang Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1,175.53

791.16

497.24

401.03

513.20

Beijing Aosaikang Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															398.34	392.83	598.78	513.20	650.80

Beijing Aosaikang Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Beijing Aosaikang Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	431.545	+	(6.754	+	74.9
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	513

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	3523.882	-	3010.682
	=	513

Beijing Aosaikang Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	570.97	+	(5.924	+	73.905
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	651

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	3686.482	-	3035.683
	=	651

Beijing Aosaikang Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Beijing Aosaikang Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Aosaikang Pharmaceutical Co (SZSE:002755) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Aosaikang Pharmaceutical Co Ltd (SZSE:002755) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

South Fourth Ring Road, Building 28 , 7th District, No. 188, Fengtai District, Beijing, CHN, 100070

Website

http://www.bnec.cn

Beijing Aosaikang Pharmaceutical Co Ltd is engaged in the research and development of domestic high-end first imitation drugs, chemical drugs, and biological drugs. Its products focus on digestion, tumors, drug-resistant infections, and chronic diseases.

Executives

Wang Zheng Yong	Executives
Li Xiao Xin	Supervisors
Ren Wei Rong	Directors, executives
Chen Qing Cai	Directors, Directors, and Executives
Du Chao Yang	Executives
Ma Yao Chuan	Director
Wu Zhan Feng	Supervisors
Guo Hong Jie	Director

Beijing Aosaikang Pharmaceutical Co (SZSE:002755) Headlines

No Headlines